Joanne Kurtzberg, MD – Autism

Access Program Information

The objective of the study is to enable access to sibling or autologous umbilical cord blood
(UCB) infusions for children with various brain disorders.

The use of UCB in this fashion is based on safety and efficacy data from prior and ongoing
clinical trials at Duke University Medical Center in over 700 patients with these diagnoses
infused with autologous or sibling UCB over the past decade.